Marcin Imieliński, MD, PhD
Core Faculty Member, NYGC Associate Professor, Department of Pathology at NYU Grossman School of Medicine; Director Cancer Genomics Research Program, NYU Langone
- Burroughs Wellcome Career Award for Medical Scientists
- Clinical Scientist Development Award from the Doris Duke Charitable Foundation
- The Black Family-MRA Team Science Award
Marcin Imieliński, MD, PhD, is a Core Faculty Member at the New York Genome Center. He holds a joint appointment as Associate Professor, Department of Pathology at NYU Grossman School of Medicine, Director of the Cancer Genetics and Genomics Research Program at the NYU Perlmutter Cancer Center,and Attending Pathologist at NYU Langone.
Dr. Imieliński is a board-certified molecular genetic pathologist. His research includes more than 100 peer-reviewed publications across several areas of genomics and computational biology. His lab uses cutting-edge sequencing technology and genomic data science to study patterns of structural and noncoding somatic DNA variation in cancer. He is specifically interested in probing long-range cancer genome structure through the use of cutting-edge sequencing protocols and the development of novel machine learning and data visualization approaches. Dr. Imieliński is particularly interested in implementing whole genome diagnostics in the oncology clinic and identifying new cancer therapies linked to whole genome biomarkers.
He is a recipient of a Burroughs Wellcome Career Award for Medical Scientists, Pershing Square Sohn Prize, Clinical Scientist Development Award from the Doris Duke Charitable Foundation, and The Black Family-MRA Team Science Award.
Dr. Imieliński received a BS in Computer Science from Rutgers College. He obtained a PhD in genomics and computational biology and his MD from the University of Pennsylvania School of Medicine. He completed his residency in pathology at the Massachusetts General Hospital, fellowship in molecular genetic pathology at Brigham and Women’s Hospital and Harvard Medical School, followed by postdoctoral training in cancer genomics at the Broad Institute and Dana Farber Cancer Institute.
Prior ExperiencePrior to joining NYU, Dr. Imieliński was an associate professor of computational genomics and pathology at Weill Cornell Medicine.